Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 5/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.41 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7392866 | 0.87 | SIGMAR1 (0.46) | SIGMAR1MAOA | |
| SCHEMBL8714626 | 0.83 | TDP1 (0.43) | SIGMAR1ALDH1A1TDP1GPR52 | |
| SCHEMBL3624305 | 0.81 | TRPA1 (0.43) | SIGMAR1ALDH1A1HPGDALOX15ALOX12 | |
| SCHEMBL451147 | 0.78 | GPR52 (0.47) | GPR52 | |
| SCHEMBL106720 | 0.78 | GPR52 (0.47) | GPR52 | |
| SCHEMBL8812260 | 0.78 | TP53 (0.41) | SIGMAR1ALDH1A1HPGDALOX15ALOX12 | |
| SCHEMBL1289345 | 0.76 | MAOB (0.52) | SIGMAR1TAAR1SLC6A2CYP2A6MAOA | |
| SCHEMBL4820232 | 0.76 | KCNH2 (0.41) | SIGMAR1ALDH1A1HPGDALOX15ALOX12 | |
| SCHEMBL5677450 | 0.75 | SIGMAR1 (0.42) | SIGMAR1 | |
| SCHEMBL392681 | 0.74 | AOC3 (0.43) | SIGMAR1ALDH1A1HPGDAOC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110250444-A1 | INTERMEDIATE TRANSFER MEMBER AND METHOD OF MANUFACTURE | XEROX CORPORATION (US) | 2011-10-13 | — | — | US | claimed |
| US-8025967-B1 | Intermediate transfer member and method of manufacture | XEROX CORPORATION (US) | 2011-09-27 | — | — | US | claimed |
| CN-102159545-A | Small molecule leptin receptor modulators | ASTRAZENECA AB | 2011-08-17 | — | — | CN | claimed |
| US-7993735-B1 | Intermediate transfer member and method of manufacture | XEROX CORPORATION (US) | 2011-08-09 | — | — | US | claimed |
| EP-0586418-A1 | SUBSTITUTED TRIAZOLINONES | BAYER AG (DE) | 1994-03-16 | — | — | EP | claimed |
| US-5276008-A | Herbicides and plant growth regulators | BAYER AKTIENGESELLSCHAFT (DE) | 1994-01-04 | — | — | US | claimed |
| WO-1992020663-A1 | SUBSTITUTED TRIAZOLINONES | BAYER AKTIENGESELLSCHAFT (DE) | 1992-11-26 | — | — | WO | claimed |
| EP-0502307-A2 | Substituted 4,5-diamino-1,2,4-triazol-3-(thi)ones | BAYER AG (DE) | 1992-09-09 | — | — | EP | claimed |
| US-20170056313-A1 | NAIL COATINGS HAVING ENHANCED ADHESION | CREATIVE NAIL DESIGN, INC. (US) | 2017-03-02 | — | — | US | disclosed |
| US-20110250444-A1 | INTERMEDIATE TRANSFER MEMBER AND METHOD OF MANUFACTURE | XEROX CORPORATION (US) | 2011-10-13 | — | — | US | disclosed |
| US-8025967-B1 | Intermediate transfer member and method of manufacture | XEROX CORPORATION (US) | 2011-09-27 | — | — | US | disclosed |
| CN-102159545-A | Small molecule leptin receptor modulators | ASTRAZENECA AB | 2011-08-17 | — | — | CN | disclosed |
| US-7993735-B1 | Intermediate transfer member and method of manufacture | XEROX CORPORATION (US) | 2011-08-09 | — | — | US | disclosed |
| EP-1620447-A1 | SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS III | Exxonmobil Chemical Patents Inc. (US) | 2006-02-01 | — | — | EP | disclosed |
| US-4435324-A | Process for the preparation of 1-alkylaminoanthraquinones | BAYER AKTIENGESELLSCHAFT (DE) | 1984-03-06 | — | — | US | disclosed |
| EP-0063298-B1 | PROCESS FOR THE PREPARATION OF 1-ALKYLAMINO ANTHRAQUINONES | BAYER AG (DE) | 1984-02-22 | — | — | EP | disclosed |
| EP-0001249-A1 | Process for preparing substituted 1-aminoanthraquinones | BAYER AG (DE) | 1979-04-04 | — | — | EP | disclosed |
| US-4056544-A | Anthraquinone compounds | BAYER AKTIENGESELLSCHAFT (DT) | 1977-11-01 | — | — | US | disclosed |
| US-4041053-A | DYES OR INTERMEDIATES THEREFOR | BAYER AKTIENGESELLSCHAFT (DT) | 1977-08-09 | — | — | US | disclosed |
| US-4000167-A | DYEING POLYESTER FIBERS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170056313-A1 | NAIL COATINGS HAVING ENHANCED ADHESION | POLR1C, PIK3C3, NACA | SIGMAR1 1606/4885ALDH1A1 1567/4885HPGD 4407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.